Tag | Content |
---|
EnhancerAtlas ID | HS060-22166 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr20:61608650-61610400 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr20:61609914-61609932 | TCCTCCTTCCTTCCTCCC | - | 7.41 | KLF14 | MA0740.1 | chr20:61609132-61609146 | TGCCACGCCCACAC | + | 6.02 | KLF14 | MA0740.1 | chr20:61609198-61609212 | GGCCACGCCCACTA | + | 7.06 | KLF14 | MA0740.1 | chr20:61609228-61609242 | GGCCACGCCCACTA | + | 7.06 | Klf12 | MA0742.1 | chr20:61609198-61609213 | GGCCACGCCCACTAG | + | 6.17 | Klf12 | MA0742.1 | chr20:61609228-61609243 | GGCCACGCCCACTAG | + | 6.17 | Klf12 | MA0742.1 | chr20:61609168-61609183 | GGCCACGCCCAATAG | + | 6.21 | SP1 | MA0079.4 | chr20:61609196-61609211 | GTGGCCACGCCCACT | + | 7.06 | SP1 | MA0079.4 | chr20:61609226-61609241 | GTGGCCACGCCCACT | + | 7.06 | SP3 | MA0746.2 | chr20:61609132-61609145 | TGCCACGCCCACA | + | 6.48 | SP3 | MA0746.2 | chr20:61609198-61609211 | GGCCACGCCCACT | + | 6.92 | SP3 | MA0746.2 | chr20:61609228-61609241 | GGCCACGCCCACT | + | 6.92 | SP4 | MA0685.1 | chr20:61609130-61609147 | GATGCCACGCCCACACC | + | 6.2 | SP4 | MA0685.1 | chr20:61609196-61609213 | GTGGCCACGCCCACTAG | + | 6.7 | SP4 | MA0685.1 | chr20:61609226-61609243 | GTGGCCACGCCCACTAG | + | 6.7 | SP8 | MA0747.1 | chr20:61609133-61609145 | GCCACGCCCACA | + | 6.22 | SP8 | MA0747.1 | chr20:61609199-61609211 | GCCACGCCCACT | + | 7.22 | SP8 | MA0747.1 | chr20:61609229-61609241 | GCCACGCCCACT | + | 7.22 | SPI1 | MA0080.4 | chr20:61609470-61609484 | CACTTCCTCTTTCT | - | 6.51 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_61729 | chr20:61582322-61623045 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr20 | 61610000 | 61610200 | chr20 | 61609096 | 61609204 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH20I062977 | chr20 | 61608826 | 61609981 |
|
Enhancer Sequence | CGTCGGCAAA TCTCCATCTC CATCAAGTTT GTGGGGGCCC AGCCTAAGGC GAGACCCCAA 60 GCCCCTTGCT GGGAGGGCTC CCAGCAGACC CTCCCTATTA ATAAGGAAAA AAAGCCAAAC 120 CGAGTTGAGA GGACCACGGC AGATGACATG TTCGGCCACA ATGCCACAGG ACTCAGTCCA 180 GCCAGGAGGA AGCTGGGGAC AGATGGAGCC CTAGGGATGG GCCCAGGCAG GAGGTGCTAC 240 TGCAGGGGAT GCGGGTCTGT GGCGAGAGGG GTGACACAGG CTCCAGAGCC TGGAAAGCAG 300 GGCCCGGAGG GTCAGCCCAC AGAAAGCAGG GCCTGGAGTG TCAGCCCCAC AGAACACTCA 360 CAAGCTTGGA GGCGCCAGCC GCGCTGCTCT GATGGCTGCG CCCTGTGTGC AACGGTAAGC 420 TGTGCCTGCA ACATGGACTG TTATTACGTG TCATTATAAA CAGAATAGAA ACCCCCACCT 480 GATGCCACGC CCACACCCAC TAGAATAGCT GGCACTGTGG CCACGCCCAA TAGAATGGCT 540 GGCACGGTGG CCACGCCCAC TAGATTGGCT GGCACTGTGG CCACGCCCAC TAGAATGGCT 600 GGAACTGTGA CCCACGGGAG GATCAGGAGG GACCGAGGCT GTGGAGGGGT CCTAAGAGCC 660 TGCCTGGTGT CGGGGAGCTG CTGATGCCCC TGTTAAAGTG GAGCACGTGG AACTGGCCCC 720 CGAACCGTCC CCACCACCCT GCTGGGGCGG CCGGTCCCTG AGTGGGTACG AGGCCAGGGT 780 GGGGTCTCAC AGCTCCCGTG GGCCATCTCC CCTCCTGGCG CACTTCCTCT TTCTGGTTTT 840 AGGATGTCAC CTTGATAGAC GTCACAGAAA CCGCATACCG TTATCTGAGA AAGTAAAACA 900 CACGAGTGAG CCCAGGCATC CTCTGGGGTT TGGTCAGTAT CCTTCGAGCT GCTGGGCGTC 960 TGTGCACCGC GGGTTCCCCT GGGCCCCCTA ATGGGAAGCG TTCTCCTGCC GGGTCGTAGG 1020 GTCTCCTGTC AAGGGCAGCG GCTGTCCCAC CCCCATCTCC CTCTGCTGAG ACACCTCTGC 1080 TCGGCACCCC GCTCCCTGGG CCTCGCCAGG GACACATAGC AGGGGGCTGT GAGCCCCAGA 1140 GGCCAAGAAA ACTGCTCCCT GCTTCCAGCC CCAGACACCA CCTCGCCTGT CCCAGGTGGC 1200 TGAGAGTGGG ATCTGGGATT GGCTACTTCC TTTGGGCATC TCCCTGCCAT TCATACCCAG 1260 GCCATCCTCC TTCCTTCCTC CCCCAGGGCC AGGATGGTCC CAGGCAAGGA TGAGAGGATT 1320 GCTCACCCGA GCAAGGCCCG AAGCCTTTCC TGAAGCTCAT TTGGGCAATT GGAGGCTGGA 1380 GGTCCCCCCG CCCAGCCCAG GAAGACTCAG CCTCCGCCCC CTCCATGGCC CCTGAGTCTC 1440 AGTTCTGCTT CGGCAGCTCC TCCTGTCCCC AAGCGTCCTC TGTTCCCGCA GCCTGAGCCA 1500 GCATGGGGAA GCTGGAGACA AGCCCTGAGC AGCCGGGCCC CTCCTCCTCA GGGACCCCTC 1560 CGGAGCTGGG CACGGGCAGC ACTTCCTCAC CCCGTTGTCC TGGGGGGCCG AGCTTGGTGG 1620 ATGGCAGTGC CCAGGGACGG GGGGACCCTC GGAGGCCGGG GTGTTTCCTG TGGACACTCA 1680 GTGTGGGCTT CTCACGGGGC CTGAGGGGTT TTCAGCGAAG GAGTTGCCTC CGCCCTTTAG 1740 GCTGTTTACG 1750
|